Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Sexually Transmitted Disease (STD) Diagnosis Market Growth (Status and Outlook) 2022-2028

  • LP 4925467
  • 114 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Sexually Transmitted Disease (STD) Diagnosis will have significant change from previous year. According to our (LP Information) latest study, the global Sexually Transmitted Disease (STD) Diagnosis market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Sexually Transmitted Disease (STD) Diagnosis market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Sexually Transmitted Disease (STD) Diagnosis market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sexually Transmitted Disease (STD) Diagnosis market, reaching US$ million by the year 2028. As for the Europe Sexually Transmitted Disease (STD) Diagnosis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Sexually Transmitted Disease (STD) Diagnosis players cover Abbott, Roche, Thermo Fisher Scientific, and Aposcience, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Sexually Transmitted Disease (STD) Diagnosis market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Chlamydia testing

Syphilis testing

Gonorrhoea testing

Herpes simplex virus testing

Human papilloma virus testing

Human immunodeficiency virus testing

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Government organizations

Hospitals

Diagnostic clinics

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Abbott

Roche

Thermo Fisher Scientific

Aposcience

BCR Diagnostics

BD Medical

Biocartis

BioMerieux

Bio-Rad

Cepheid

Danaher

DiaSorin

Quidel

GenMark Diagnostics

Hologic

OraSure Technologies

Qualigen

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size 2017-2028

2.1.2 Sexually Transmitted Disease (STD) Diagnosis Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Sexually Transmitted Disease (STD) Diagnosis Segment by Type

2.2.1 Chlamydia testing

2.2.2 Syphilis testing

2.2.3 Gonorrhoea testing

2.2.4 Herpes simplex virus testing

2.2.5 Human papilloma virus testing

2.2.6 Human immunodeficiency virus testing

2.3 Sexually Transmitted Disease (STD) Diagnosis Market Size by Type

2.3.1 Sexually Transmitted Disease (STD) Diagnosis Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Type (2017-2022)

2.4 Sexually Transmitted Disease (STD) Diagnosis Segment by Application

2.4.1 Government organizations

2.4.2 Hospitals

2.4.3 Diagnostic clinics

2.5 Sexually Transmitted Disease (STD) Diagnosis Market Size by Application

2.5.1 Sexually Transmitted Disease (STD) Diagnosis Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Application (2017-2022)

3 Sexually Transmitted Disease (STD) Diagnosis Market Size by Player

3.1 Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Players

3.1.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Players (2020-2022)

3.1.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Players (2020-2022)

3.2 Global Sexually Transmitted Disease (STD) Diagnosis Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Sexually Transmitted Disease (STD) Diagnosis by Regions

4.1 Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions (2017-2022)

4.2 Americas Sexually Transmitted Disease (STD) Diagnosis Market Size Growth (2017-2022)

4.3 APAC Sexually Transmitted Disease (STD) Diagnosis Market Size Growth (2017-2022)

4.4 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size Growth (2017-2022)

4.5 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Growth (2017-2022)

5 Americas

5.1 Americas Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2017-2022)

5.2 Americas Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2017-2022)

5.3 Americas Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2017-2022)

6.2 APAC Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2017-2022)

6.3 APAC Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Sexually Transmitted Disease (STD) Diagnosis by Country (2017-2022)

7.2 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2017-2022)

7.3 Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis by Region (2017-2022)

8.2 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2017-2022)

8.3 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.1 Global Sexually Transmitted Disease (STD) Diagnosis Forecast by Regions (2023-2028)

10.1.1 Global Sexually Transmitted Disease (STD) Diagnosis Forecast by Regions (2023-2028)

10.1.2 Americas Sexually Transmitted Disease (STD) Diagnosis Forecast

10.1.3 APAC Sexually Transmitted Disease (STD) Diagnosis Forecast

10.1.4 Europe Sexually Transmitted Disease (STD) Diagnosis Forecast

10.1.5 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Forecast

10.2 Americas Sexually Transmitted Disease (STD) Diagnosis Forecast by Country (2023-2028)

10.2.1 United States Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.2.2 Canada Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.2.3 Mexico Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.2.4 Brazil Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.3 APAC Sexually Transmitted Disease (STD) Diagnosis Forecast by Region (2023-2028)

10.3.1 China Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.3.2 Japan Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.3.3 Korea Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.3.4 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.3.5 India Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.3.6 Australia Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.4 Europe Sexually Transmitted Disease (STD) Diagnosis Forecast by Country (2023-2028)

10.4.1 Germany Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.4.2 France Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.4.3 UK Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.4.4 Italy Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.4.5 Russia Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.5 Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Forecast by Region (2023-2028)

10.5.1 Egypt Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.5.2 South Africa Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.5.3 Israel Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.5.4 Turkey Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.5.5 GCC Countries Sexually Transmitted Disease (STD) Diagnosis Market Forecast

10.6 Global Sexually Transmitted Disease (STD) Diagnosis Forecast by Type (2023-2028)

10.7 Global Sexually Transmitted Disease (STD) Diagnosis Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Abbott

11.1.1 Abbott Company Information

11.1.2 Abbott Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Abbott Main Business Overview

11.1.5 Abbott Latest Developments

11.2 Roche

11.2.1 Roche Company Information

11.2.2 Roche Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Roche Main Business Overview

11.2.5 Roche Latest Developments

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Information

11.3.2 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Thermo Fisher Scientific Main Business Overview

11.3.5 Thermo Fisher Scientific Latest Developments

11.4 Aposcience

11.4.1 Aposcience Company Information

11.4.2 Aposcience Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Aposcience Main Business Overview

11.4.5 Aposcience Latest Developments

11.5 BCR Diagnostics

11.5.1 BCR Diagnostics Company Information

11.5.2 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 BCR Diagnostics Main Business Overview

11.5.5 BCR Diagnostics Latest Developments

11.6 BD Medical

11.6.1 BD Medical Company Information

11.6.2 BD Medical Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 BD Medical Main Business Overview

11.6.5 BD Medical Latest Developments

11.7 Biocartis

11.7.1 Biocartis Company Information

11.7.2 Biocartis Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Biocartis Main Business Overview

11.7.5 Biocartis Latest Developments

11.8 BioMerieux

11.8.1 BioMerieux Company Information

11.8.2 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.8.3 BioMerieux Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 BioMerieux Main Business Overview

11.8.5 BioMerieux Latest Developments

11.9 Bio-Rad

11.9.1 Bio-Rad Company Information

11.9.2 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Bio-Rad Main Business Overview

11.9.5 Bio-Rad Latest Developments

11.10 Cepheid

11.10.1 Cepheid Company Information

11.10.2 Cepheid Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Cepheid Main Business Overview

11.10.5 Cepheid Latest Developments

11.11 Danaher

11.11.1 Danaher Company Information

11.11.2 Danaher Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Danaher Main Business Overview

11.11.5 Danaher Latest Developments

11.12 DiaSorin

11.12.1 DiaSorin Company Information

11.12.2 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 DiaSorin Main Business Overview

11.12.5 DiaSorin Latest Developments

11.13 Quidel

11.13.1 Quidel Company Information

11.13.2 Quidel Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Quidel Main Business Overview

11.13.5 Quidel Latest Developments

11.14 GenMark Diagnostics

11.14.1 GenMark Diagnostics Company Information

11.14.2 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 GenMark Diagnostics Main Business Overview

11.14.5 GenMark Diagnostics Latest Developments

11.15 Hologic

11.15.1 Hologic Company Information

11.15.2 Hologic Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Hologic Main Business Overview

11.15.5 Hologic Latest Developments

11.16 OraSure Technologies

11.16.1 OraSure Technologies Company Information

11.16.2 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 OraSure Technologies Main Business Overview

11.16.5 OraSure Technologies Latest Developments

11.17 Qualigen

11.17.1 Qualigen Company Information

11.17.2 Qualigen Sexually Transmitted Disease (STD) Diagnosis Product Offered

11.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Qualigen Main Business Overview

11.17.5 Qualigen Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Sexually Transmitted Disease (STD) Diagnosis Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Chlamydia testing

Table 3. Major Players of Syphilis testing

Table 4. Major Players of Gonorrhoea testing

Table 5. Major Players of Herpes simplex virus testing

Table 6. Major Players of Human papilloma virus testing

Table 7. Major Players of Human immunodeficiency virus testing

Table 8. Sexually Transmitted Disease (STD) Diagnosis Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 9. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2017-2022) & ($ Millions)

Table 10. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Type (2017-2022)

Table 11. Sexually Transmitted Disease (STD) Diagnosis Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 12. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2017-2022) & ($ Millions)

Table 13. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Application (2017-2022)

Table 14. Global Sexually Transmitted Disease (STD) Diagnosis Revenue by Players (2020-2022) & ($ Millions)

Table 15. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Player (2020-2022)

Table 16. Sexually Transmitted Disease (STD) Diagnosis Key Players Head office and Products Offered

Table 17. Sexually Transmitted Disease (STD) Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 18. New Products and Potential Entrants

Table 19. Mergers & Acquisitions, Expansion

Table 20. Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions 2017-2022 & ($ Millions)

Table 21. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Regions (2017-2022)

Table 22. Americas Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2017-2022) & ($ Millions)

Table 23. Americas Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Country (2017-2022)

Table 24. Americas Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2017-2022) & ($ Millions)

Table 25. Americas Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Type (2017-2022)

Table 26. Americas Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2017-2022) & ($ Millions)

Table 27. Americas Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Application (2017-2022)

Table 28. APAC Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2017-2022) & ($ Millions)

Table 29. APAC Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Region (2017-2022)

Table 30. APAC Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2017-2022) & ($ Millions)

Table 31. APAC Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Type (2017-2022)

Table 32. APAC Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2017-2022) & ($ Millions)

Table 33. APAC Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Application (2017-2022)

Table 34. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Country (2017-2022) & ($ Millions)

Table 35. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Country (2017-2022)

Table 36. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2017-2022) & ($ Millions)

Table 37. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Type (2017-2022)

Table 38. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2017-2022) & ($ Millions)

Table 39. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Application (2017-2022)

Table 40. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Region (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Region (2017-2022)

Table 42. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Type (2017-2022) & ($ Millions)

Table 43. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Type (2017-2022)

Table 44. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size by Application (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Application (2017-2022)

Table 46. Key Market Drivers & Growth Opportunities of Sexually Transmitted Disease (STD) Diagnosis

Table 47. Key Market Challenges & Risks of Sexually Transmitted Disease (STD) Diagnosis

Table 48. Key Industry Trends of Sexually Transmitted Disease (STD) Diagnosis

Table 49. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 50. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share Forecast by Regions (2023-2028)

Table 51. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 52. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share Forecast by Type (2023-2028)

Table 53. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 54. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share Forecast by Application (2023-2028)

Table 55. Abbott Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 56. Abbott Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 57. Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 58. Abbott Main Business

Table 59. Abbott Latest Developments

Table 60. Roche Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 61. Roche Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 62. Roche Main Business

Table 63. Roche Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 64. Roche Latest Developments

Table 65. Thermo Fisher Scientific Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 66. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 67. Thermo Fisher Scientific Main Business

Table 68. Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 69. Thermo Fisher Scientific Latest Developments

Table 70. Aposcience Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 71. Aposcience Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 72. Aposcience Main Business

Table 73. Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 74. Aposcience Latest Developments

Table 75. BCR Diagnostics Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 76. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 77. BCR Diagnostics Main Business

Table 78. BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 79. BCR Diagnostics Latest Developments

Table 80. BD Medical Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 81. BD Medical Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 82. BD Medical Main Business

Table 83. BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 84. BD Medical Latest Developments

Table 85. Biocartis Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 86. Biocartis Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 87. Biocartis Main Business

Table 88. Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 89. Biocartis Latest Developments

Table 90. BioMerieux Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 91. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 92. BioMerieux Main Business

Table 93. BioMerieux Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 94. BioMerieux Latest Developments

Table 95. Bio-Rad Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 96. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 97. Bio-Rad Main Business

Table 98. Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 99. Bio-Rad Latest Developments

Table 100. Cepheid Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 101. Cepheid Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 102. Cepheid Main Business

Table 103. Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Cepheid Latest Developments

Table 105. Danaher Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 106. Danaher Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 107. Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 108. Danaher Main Business

Table 109. Danaher Latest Developments

Table 110. DiaSorin Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 111. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 112. DiaSorin Main Business

Table 113. DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 114. DiaSorin Latest Developments

Table 115. Quidel Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 116. Quidel Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 117. Quidel Main Business

Table 118. Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 119. Quidel Latest Developments

Table 120. GenMark Diagnostics Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 121. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 122. GenMark Diagnostics Main Business

Table 123. GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 124. GenMark Diagnostics Latest Developments

Table 125. Hologic Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 126. Hologic Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 127. Hologic Main Business

Table 128. Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 129. Hologic Latest Developments

Table 130. OraSure Technologies Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 131. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 132. OraSure Technologies Main Business

Table 133. OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 134. OraSure Technologies Latest Developments

Table 135. Qualigen Details, Company Type, Sexually Transmitted Disease (STD) Diagnosis Area Served and Its Competitors

Table 136. Qualigen Sexually Transmitted Disease (STD) Diagnosis Product Offered

Table 137. Qualigen Main Business

Table 138. Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 139. Qualigen Latest Developments

List of Figures

Figure 1. Sexually Transmitted Disease (STD) Diagnosis Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Type in 2021

Figure 7. Sexually Transmitted Disease (STD) Diagnosis in Government organizations

Figure 8. Global Sexually Transmitted Disease (STD) Diagnosis Market: Government organizations (2017-2022) & ($ Millions)

Figure 9. Sexually Transmitted Disease (STD) Diagnosis in Hospitals

Figure 10. Global Sexually Transmitted Disease (STD) Diagnosis Market: Hospitals (2017-2022) & ($ Millions)

Figure 11. Sexually Transmitted Disease (STD) Diagnosis in Diagnostic clinics

Figure 12. Global Sexually Transmitted Disease (STD) Diagnosis Market: Diagnostic clinics (2017-2022) & ($ Millions)

Figure 13. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Application in 2021

Figure 14. Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Player in 2021

Figure 15. Global Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Sexually Transmitted Disease (STD) Diagnosis Market Size 2017-2022 ($ Millions)

Figure 17. APAC Sexually Transmitted Disease (STD) Diagnosis Market Size 2017-2022 ($ Millions)

Figure 18. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size 2017-2022 ($ Millions)

Figure 20. Americas Sexually Transmitted Disease (STD) Diagnosis Value Market Share by Country in 2021

Figure 21. Americas Sexually Transmitted Disease (STD) Diagnosis Consumption Market Share by Type in 2021

Figure 22. Americas Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Application in 2021

Figure 23. United States Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Region in 2021

Figure 28. APAC Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Application in 2021

Figure 29. China Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Country in 2021

Figure 36. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Type in 2021

Figure 37. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Application in 2021

Figure 38. Germany Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Market Share by Application in 2021

Figure 46. Egypt Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Sexually Transmitted Disease (STD) Diagnosis Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 52. APAC Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 53. Europe Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 55. United States Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 56. Canada Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 59. China Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 60. Japan Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 61. Korea Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 63. India Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 64. Australia Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 65. Germany Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 66. France Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 67. UK Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 68. Italy Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 69. Russia Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 70. Spain Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 73. Israel Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Sexually Transmitted Disease (STD) Diagnosis Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450